S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › 064550 › Research report
← 064550 page
XStocksXray
Market X-Ray report · 19 October 2026

Bioneer Corporation (064550)

KOSDAQ · Korea · prices in KRW · close of 19 Oct 2026

Key indicators

Last closeKRW 8,010.00
52-week range5,470.00 – 15,640.00
Return, 1 month / 3 months−15.7% / +32.4%
Return, 1 year / 3 years−42.7% / −80.8%
TrendBelow its 200-day average
RSI (14)44
Volatility (1 year)69.0%
Worst drawdown (1 year)-62.6%
Average daily value traded4,634.56M KRW
Dividend yield–

Market X-Ray price-based

56/ 100 · High confidence · ahead of 59% of stocks on this exchange
Trend48
Momentum57
Stability (higher is calmer)44
Liquidity86
Income–

Five-year price chart navy: price · brown: 200-day average

1,68520,84039,99559,15078,3052021-102023-012024-042025-072026-10

About the company

Bioneer Corporation is a Korean biotechnology company based in Daejeon that supplies tools and reagents for molecular biology research and diagnostics. It produces synthetic oligonucleotides, nucleic acid extraction kits, PCR reagents and laboratory instruments such as thermal cyclers and real-time PCR systems. Its customers include research laboratories, universities, hospitals and diagnostic testing facilities that work with genetic material. The company also develops molecular diagnostic products and related platform technologies for clinical and research use.

Bioneer Corporation trades under the code 064550 on the KOSDAQ in Korea, with its price quoted in South Korean won (KRW). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Bioneer Corporation (064550) trades on the KOSDAQ in Korea. It last closed at KRW 8,010.00 on 19 October 2026.

Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 750 of 1,830 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 42.7% and over the last three months it rose 32.4%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Bioneer Corporation (064550)

The five lenses in numbers each metric is ranked against the other stocks on KOSDAQ

Lens and metricValueScoreReading
Trend48 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-18.7%
From 52-week high-48.3%
Momentum57 · FairTypical recent returns for this exchange.
3-month return32.4%
6-month return-23.3%
12-month return, skipping the last month-32.0%
Stability (higher is calmer)44 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)69.0%
Worst drawdown, 1 year (smaller is calmer)-62.6%
Liquidity86 · StrongTrades actively.
Average daily value traded4,634.56M KRW
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−1.1%
1 month−15.7%
3 months+32.4%
6 months−23.3%
1 year−42.7%
3 years−80.8%
5 years–

Signals

50-day / 200-day average8,577.20 / 9,850.80
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)520.44

Technical summary

DailyStrongly bearish1 bullish · 4 neutral · 11 bearish
WeeklyStrongly bearish2 bullish · 1 neutral · 9 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on KOSDAQ; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026